References
<A NAME="RG31802ST-1">1</A>
Greene TW.
Wuts PGM.
Protective Groups in Organic Synthesis
Wiley;
New
York:
1991.
<A NAME="RG31802ST-2">2</A>
Vogl C, and
Aebi R. inventors; German Patent 2328340.
; Chem. Abstr. 1974, 80, 82440
<A NAME="RG31802ST-3">3</A>
Vogl C, and
Aebi R. inventors; Swiss Patent 576945.
; Chem. Abstr. 1976, 85, 142866
<A NAME="RG31802ST-4">4</A>
Vogl C, and
Aebi R. inventors; Swiss Patent 581607.
; Chem. Abstr. 1977, 86, 72242
<A NAME="RG31802ST-5">5</A>
Vogl C, and
Aebi R. inventors; U.S. Patent 4160660.
; Chem. Abstr. 1979, 91, 118677
<A NAME="RG31802ST-6">6</A>
Kolpin DW.
Nations BK.
Goolsby DA.
Thurman EM.
Environ.
Sci. Technol.
1996,
30:
1459
<A NAME="RG31802ST-7">7</A>
Venkov AP.
Minkov MM.
Lukanov LK.
Synth. Commun.
1989,
19:
2133
<A NAME="RG31802ST-8">8</A>
Jacobsen NE.
Sanders M.
Toia RF.
Casida JE.
J. Agric. Food Chem.
1991,
39:
1342
<A NAME="RG31802ST-9">9</A>
Olah GA.
Laali KK.
Wang Q.
Surya Prakash GK.
Onium Ions
Wiley;
New
York:
1998.
<A NAME="RG31802ST-10">10</A>
Zupancic BG.
Sobcic M.
Synthesis
1982,
942
<A NAME="RG31802ST-11">11</A>
Danikiewicz W.
Szmigielski R.
Synth. Commun.
2001,
31:
3047
<A NAME="RG31802ST-12">12</A>
Blair A.
Kazerouni N.
Cancer Causes Control
1997,
8:
473
<A NAME="RG31802ST-13">13</A>
Bicking JB.
Kwong SF.
Fisher MH.
Nicholson WH.
J.
Med. Chem.
1965,
8:
95
<A NAME="RG31802ST-14">14</A>
Cauliez P.
Rigo B.
Fasseur D.
Couturier D.
J. Heterocycl. Chem.
1991,
28:
1143
<A NAME="RG31802ST-15">15</A>
Alkoxymethylation
of Secondary Amides, Sulfonamides or Phosphamides - Representative
Example: To a solution of 1-chloro-N-phenylmethanesulfonamide
(1.03 g, 5 mmol) in dialkoxymethane (24 mL, 0.27 mol) boron trifluoride
etherate (0.76 mL, 6 mmol) was added and
the mixture was refluxed during 5 h under argon atmosphere. After
cooling to r.t. the reaction mixture was treated with 3 mL of the
sat. aq K2CO3 and the aq solution extracted
with EtOAc (3 × 20 mL). The combined
organic layers were dried with Na2SO4 and
the solvent evaporated under reduced pressure. The crude product
was purified by crystallization from hexane/EtOAc yielding
1.14 g (91% yield, mp 65-66 °C, lit.
[17]
mp 67-68 °C)
of 1-chloro-N-(methoxymethyl)-N-phenylmethanesulfonamide (12) as white crystals.
<A NAME="RG31802ST-16">16</A>
Properties of new compounds:
N
-Benzyl-
N
-(methoxymethyl)acetamide(5). 1H NMR (400 MHz,
CDCl3): δ = 2.24 (s, 3 H, CH
3CO), 3.28 (s, 3 H, CH
3O), 4.60 (s, 2 H, PhCH
2), 4.67 (s, 2 H, NCH
2O), 7.18-7.38 (s,
5 H, Ph). 13C NMR (400 MHz, CDCl3): δ = 21.3 (CH3CO), 48.0 (PhCH2), 55.3 (CH3O),
79.5 (NCH2O), 127.3 (Ph),
128.1 (Ph), 128.5 (Ph), 137.4 (Ph), 171.4 (CO). MS:
m/z (%) = 193
(1) [M+], 162 (12), 161 (71),
148 (6), 120 (31), 119 (48), 118 (30), 106 (100), 92 (8), 91 (93),
79 (10), 65 (13), 60 (14), 45 (23), 43 (48). HRMS calcd for C11H15NO2: 193.1102.
Found: 193.1113.
2-[(Ethoxymethoxy)methyl]-1
H
-isoindole-1,3-(2
H
)-dione(8c). 1H NMR (400 MHz,
CDCl3): δ = 1.08 (t, 3 H, 3
J = 7.1 Hz,
CH
3CH2O), 3.56
(q, 2 H, 3
J = 7.1
Hz, CH3CH
2O), 4.76
(s, 2 H, OCH
2O), 5.18 (s,
2 H, NCH
2O), 7.65-7.89
(m, 4 H, ArH). 13C
NMR (400 MHz, CDCl3): δ = 14.8 (CH3CH2O), 63.6
(CH3
CH2O), 64.5
(NCH2O), 94.3 (OCH2O), 123.5 (Ar), 131.8 (Ar),
134.2 (Ar), 167.5 (CO). LSIMS MS: m/z = 258 [M + Na+].
Anal. Calcd for C12H13NO4: C, 61.25;
H, 5.57; N, 5.96. Found: C, 61.09; H, 5.49; N, 6.00. Mp: 61.5-62 °C
(hexane/EtOAc).
2-(Methoxymethyl)-2
H
-naphtho[1,8-
cd
]isothiazole
1,1-dioxide(13a). 1H
NMR (400 MHz, CDCl3): δ = 3.52 (s,
3 H, CH
3O), 5.26 (s, 2 H,
NCH
2O), 6.96-8.14
(m, 6 H, ArH). 13C NMR
(400 MHz, CDCl3): δ = 56.7 (CH3O), 74.4 (NCH2O), 104.6 (Ar), 119.0 (Ar),
119.1 (Ar), 119.9 (Ar), 128.1 (Ar), 129.4 (Ar), 130.1 (Ar), 130.6
(Ar), 131.3 (Ar), 135.5 (Ar). MS: m/z (%) = 249 (23) [M+],
219 (21), 218 (9), 188 (4), 154 (7), 127 (10), 77 (5), 75 (7), 74
(5), 61 (14), 45 (100), 33 (4). HRMS calcd for C12H11NO3S:
249.0439. Found: 249.0459. Mp: 90-91.5 °C (hexane/EtOAc).
2-(Ethoxymethyl)-2
H
-naphtho[1,8-
cd
]isothiazole 1,1-dioxide(13b). 1H NMR (400 MHz,
CDCl3): δ = 1.24 (t, 3 H, 3
J = 6.8 Hz,
CH
3CH2O), 3.75
(q, 2 H, 3
J = 6.8
Hz, CH3CH
2O), 5.30
(s, 2 H, NCH
2O), 7.07-8.14
(m, 6 H, ArH). 13C
NMR (400 MHz, CDCl3): δ = 14.7 (CH3CH2O), 64.6 (CH3
CH2O), 72.8 (NCH2O), 104.6 (Ar), 118.9 (Ar),
119.0 (Ar), 119.8 (Ar), 128.0 (Ar), 129.4 (Ar), 130.1 (Ar), 130.6 (Ar),
131.3 (Ar), 135.6 (Ar). MS: m/z (%) = 263 (47) [M+], 233
(19), 219 (7), 218 (42), 205 (100), 172 (5), 141 (48), 140 (17),
128 (7), 127 (38), 115 (8), 114 (16), 113 (7), 77 (17), 63 (10),
59 (64), 43 (10). HRMS calcd for C13H13NO3S: 263.0616.
Found: 263.0622. Mp: 130-131 °C (hexane/EtOAc).
3-(Methoxymethyl)-3
H
-1,2,3-benzoxathiazole 2,2-dioxide(14). 1H NMR (500 MHz,
acetone-d
6): δ = 3.49
(s, 3 H, CH
3O), 5.28 (s, 2
H, NCH
2O), 7.13-7.34
(m, 4 H, ArH). 13C
NMR (500 MHz, acetone-d
6): δ = 57.0
(CH3O), 78.1 (NCH2O), 111.9 (Ar), 112.2 (Ar),
124.0 (Ar), 126.1 (Ar), 131.4 (Ar), 142.1 (Ar). MS: m/z (%) = 179
(37) [M+·], 164 (2),
149 (9), 148 (14), 135 (2), 134 (3), 120 (4), 78 (4), 77 (17), 65
(4), 52 (3), 51 (8), 45 (100), 39 (3). HRMS calcd for C9H9NO3:
179.0582. Found: 179.0575.
N
-(Methoxymethyl)-
N
,
P
,
P
-triphenylphosphinic Amide(16). 1H
NMR (400 MHz, DMSO-d
6): δ = 3.09
(s,
3 H, CH
3O), 4.62
(d, 2 H, 3
J = 13.2
Hz, NCH
2O), 6.94-7.90 (m,
15 H, Ph). 13C NMR (500 MHz, DMSO-d
6): δ = 54.7 (CH3O), 82.4 (d, 1 C, 2
J = 6.4 Hz,
NCH2O), 124.9 (Ph), 125.6
(Ph), 125.7 (Ph), 128.4 (Ph), 128.5 (Ph), 128.7 (Ph), 130.8 (Ph),
131.8 (Ph), 131.9 (Ph), 132.2 (Ph), 132.3 (Ph), 134.8 (Ph), 143.3
(Ph) (Note: number of signals is higher than the number of carbon
atoms due to the 13C - 31P coupling
in the aromatic rings). MS: m/z (%) = 337 (1) [M+·], 307
(1), 306 (3), 291 (1), 232 (37), 231 (100), 220 (16), 219 (37),
213 (4), 202 (15), 201 (14), 200 (8), 199 (52), 155 (19), 153 (6),
152 (13), 136 (10), 134 (13), 125 (5), 109 (9), 106 (7), 92 (12),
91 (11), 78 (9), 77 (54), 62 (12), 51 (24), 47 (8), 45 (25), 43
(24). HRMS calcd for C20H20NO2P:
337.1231. Found: 337.1225.
<A NAME="RG31802ST-17">17</A>
Danikiewicz W.
Wojciechowski K.
Rapid Commun. Mass Spectrom.
1996,
10:
36